First Trust NYSE Arca Biotechnology Index Fund
93 hedge funds and large institutions have $794M invested in First Trust NYSE Arca Biotechnology Index Fund in 2014 Q2 according to their latest regulatory filings, with 16 funds opening new positions, 46 increasing their positions, 25 reducing their positions, and 7 closing their positions.
129% more first-time investments, than exits
New positions opened: 16 | Existing positions closed: 7
84% more repeat investments, than reductions
Existing positions increased: 46 | Existing positions reduced: 25
23% more capital invested
Capital invested by funds: $648M → $794M (+$146M)
11% more funds holding
Funds holding: 84 → 93 (+9)
1.04% more ownership
Funds ownership: 54.51% → 55.55% (+1%)
12% less call options, than puts
Call options by funds: $2.12M | Put options by funds: $2.42M
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
First Trust Advisors
Wheaton,
Illinois
|
+$45.2M |
| 2 |
RIG
RiverFront Investment Group
Richmond,
Virginia
|
+$30.8M |
| 3 |
U
UBS
Zurich,
Switzerland
|
+$8.36M |
| 4 |
BTS
BB&T Securities
Richmond,
Virginia
|
+$6.25M |
| 5 |
HighTower Advisors
Chicago,
Illinois
|
+$3.03M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Goldman Sachs
New York
|
-$34.9M |
| 2 |
Morgan Stanley
New York
|
-$10.6M |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$5.68M |
| 4 |
Wells Fargo
San Francisco,
California
|
-$4.61M |
| 5 |
VF
Virtu Financial
New York
|
-$3.7M |
FBT Hedge Fund Activity: Q2 2014 in Review
93 of the 3,480 institutional investors tracked by Wall St. Rank reported a position in First Trust NYSE Arca Biotechnology Index Fund (FBT) for Q2 2014, worth a combined $794M — up 23% from $648M a quarter earlier.
Buyers outnumbered sellers: 16 funds opened new FBT positions and 7 closed out — a net gain of 9 holders — while 46 added to existing stakes and 25 trimmed.
The largest buyer was First Trust Advisors, adding an estimated $45.2M. The largest seller was Goldman Sachs, cutting an estimated $34.9M.
- 93 institutional investors held First Trust NYSE Arca Biotechnology Index Fund (FBT) as of Q2 2014, up from 84 in Q1 2014.
- Funds reported $794M of First Trust NYSE Arca Biotechnology Index Fund stock for Q2 2014, up 23% quarter-over-quarter.
- 16 funds opened new First Trust NYSE Arca Biotechnology Index Fund positions in Q2 2014 and 7 closed out, a net change of +9 holders.
- The largest First Trust NYSE Arca Biotechnology Index Fund buyer in Q2 2014 was First Trust Advisors, an estimated $45.2M added.
- The largest First Trust NYSE Arca Biotechnology Index Fund seller in Q2 2014 was Goldman Sachs, an estimated $34.9M sold.
Based on aggregated 13F filings for Q2 2014.